← Back to Search

Arm 1 for Diabetes (GLEAM Trial)

N/A

Waitlist Available

Research Sponsored by Pennington Biomedical Research Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up once at study visit 1 day and 1 day at study visit 3, 14 days apart

Awards & highlights

GLEAM Trial Summary

This trial showed that there is a relationship between the rate of GAM and susceptibility to insulin-induced hypoglycemia, which may help to maintain healthy glucose levels in people with diabetes.

Eligible Conditions

Diabetes
Low Blood Sugar

GLEAM Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ once at study visit 1 day and 1 day at study visit 3, 14 days apart

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~once at study visit 1 day and 1 day at study visit 3, 14 days apart

This trial's timeline: 3 weeks for screening, Varies for treatment, and once at study visit 1 day and 1 day at study visit 3, 14 days apart for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in percent 13C enrichment of bicarbonate measured via carbon-13 magnetic resonance spectroscopy (13C-MRS)

GLEAM Trial Design

1Treatment groups

Experimental Treatment

Group I: Arm 1Experimental Treatment2 Interventions

Participants will have there glial acetate metabolism assessed via 13C MRS at baseline and then again 14 days later. Participants will wear blinded continuous glucose monitoring devices for ~4 weeks.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Continuous glucose monitoring

2019

N/A

~580

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Pennington Biomedical Research CenterLead Sponsor

304 Previous Clinical Trials

181,428 Total Patients Enrolled

6 Trials studying Diabetes

1,425 Patients Enrolled for Diabetes

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To whom is the opportunity to participate in this clinical trial available?

"Investigators are looking for 8 individuals, aged 18-40 years old and exhibiting hypoglycemia symptoms, to take part in a continuous glucose monitoring (CGM) study. Furthermore, participants must have Modified Clarke's Hypoglycemia Questionnaire scores between 12-24."

Answered by AI

Can persons over the age of sixty participate in this experiment?

"This clinical trial is restricted to individuals aged 18-40 years old. For those outside this age range, there are 33 trials for minors and 201 studies for senior citizens."

Answered by AI

Has recruitment for this clinical trial been opened to the public?

"Data from clinicaltrials.gov indicates this trial is no longer enrolling patients; the original posting date was August 19th 2020, with the last update on September 20th 2022. However, there are 257 other medical studies actively recruiting at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Complications in Diabetic Patients

David McDougal 2020. "Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Complications in Diabetic Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04430660.